Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
Effects of copper and ceruloplasmin on iron transport in the Caco 2 cell intestinal model.

The Journal of nutritional biochemistry

Zerounian NR, Linder MC.
PMID: 11893478
J Nutr Biochem. 2002 Mar;13(3):138-148. doi: 10.1016/s0955-2863(01)00205-4.

Previous studies have implicated copper proteins, including ceruloplasmin, in intestinal iron transport. Polarized Caco2 cells with tight junctions were used to examine the possibilities that (a) ceruloplasmin promotes iron absorption by enhancing release at the basolateral cell surface and...

Cite
Zerounian NR, Linder MC. Effects of copper and ceruloplasmin on iron transport in the Caco 2 cell intestinal model. J Nutr Biochem. 2002;13(3):138-148doi: 10.1016/s0955-2863(01)00205-4.
Zerounian, N. R., & Linder, M. C. (2002). Effects of copper and ceruloplasmin on iron transport in the Caco 2 cell intestinal model. The Journal of nutritional biochemistry, 13(3), 138-148. https://doi.org/10.1016/s0955-2863(01)00205-4
Zerounian, Nora R., and Linder, Maria C.. "Effects of copper and ceruloplasmin on iron transport in the Caco 2 cell intestinal model." The Journal of nutritional biochemistry vol. 13,3 (2002): 138-148. doi: https://doi.org/10.1016/s0955-2863(01)00205-4
Zerounian NR, Linder MC. Effects of copper and ceruloplasmin on iron transport in the Caco 2 cell intestinal model. J Nutr Biochem. 2002 Mar;13(3):138-148. doi: 10.1016/s0955-2863(01)00205-4. PMID: 11893478.
Copy Download .nbib Format: NLM
Transferrin as a source of iron for Campylobacter rectus.

Journal of oral microbiology

Grenier D, Tanabe S.
PMID: 21547017
J Oral Microbiol. 2011 Jan 12;3. doi: 10.3402/jom.v3i0.5660.

BACKGROUND AND OBJECTIVE: Campylobacter rectus is considered as one of the bacterial species of etiological importance in periodontitis. Iron-containing proteins such as transferrin are found in periodontal sites and may serve as a source of iron for periodontopathogens. The...

Cite
Grenier D, Tanabe S. Transferrin as a source of iron for Campylobacter rectus. J Oral Microbiol. 2011;3doi: 10.3402/jom.v3i0.5660.
Grenier, D., & Tanabe, S. (2011). Transferrin as a source of iron for Campylobacter rectus. Journal of oral microbiology, 3. https://doi.org/10.3402/jom.v3i0.5660
Grenier, Daniel, and Tanabe, Shin-Ichi. "Transferrin as a source of iron for Campylobacter rectus." Journal of oral microbiology vol. 3 (2011). doi: https://doi.org/10.3402/jom.v3i0.5660
Grenier D, Tanabe S. Transferrin as a source of iron for Campylobacter rectus. J Oral Microbiol. 2011 Jan 12;3. doi: 10.3402/jom.v3i0.5660. PMID: 21547017; PMCID: PMC3087192.
Copy Download .nbib Format: NLM
Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes.

Molecular therapy. Nucleic acids

Chakraborty S, Dlie ZY, Chakraborty S, Roy S, Mukherjee B, Besra SE, Dewanjee S, Mukherjee A, Ojha PK, Kumar V, Sen R.
PMID: 32146417
Mol Ther Nucleic Acids. 2020 Jun 05;20:34-49. doi: 10.1016/j.omtn.2020.01.034. Epub 2020 Feb 05.

Site-specific delivery of chemotherapeutics specifically to neoplastic hepatocytes without affecting normal hepatocytes should be a focus for potential therapeutic management of hepatocellular carcinoma (HCC). The aptamer TLS 9a with phosphorothioate backbone modifications (L5) has not been explored so far...

Cite
Chakraborty S, Dlie ZY, Chakraborty S, et al. Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes. Mol Ther Nucleic Acids. 2020;20:34-49doi: 10.1016/j.omtn.2020.01.034.
Chakraborty, S., Dlie, Z. Y., Chakraborty, S., Roy, S., Mukherjee, B., Besra, S. E., Dewanjee, S., Mukherjee, A., Ojha, P. K., Kumar, V., & Sen, R. (2020). Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes. Molecular therapy. Nucleic acids, 2034-49. https://doi.org/10.1016/j.omtn.2020.01.034
Chakraborty, Samrat, et al. "Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes." Molecular therapy. Nucleic acids vol. 20 (2020): 34-49. doi: https://doi.org/10.1016/j.omtn.2020.01.034
Chakraborty S, Dlie ZY, Chakraborty S, Roy S, Mukherjee B, Besra SE, Dewanjee S, Mukherjee A, Ojha PK, Kumar V, Sen R. Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes. Mol Ther Nucleic Acids. 2020 Jun 05;20:34-49. doi: 10.1016/j.omtn.2020.01.034. Epub 2020 Feb 05. PMID: 32146417; PMCID: PMC7063179.
Copy Download .nbib Format: NLM
Vanadate complexes in serum: a speciation modeling study.

Dalton transactions (Cambridge, England : 2003)

Jakusch T, Dean A, Oncsik T, Bényei AC, Di Marco V, Kiss T.
PMID: 20023952
Dalton Trans. 2010 Jan 07;(1):212-20. doi: 10.1039/b914849c. Epub 2009 Nov 05.

The speciations of two drug candidate ligands, 2-hydroxypyridine-N-oxide (Hhpno) and 2-mercaptopyridine-N-oxide (Hmpno), with vanadate (V(V)) were determined at 25.0 degrees C and 0.20 mol dm(-3) KCl by pH-metric and (51)V-NMR methods. At pH 7.4, the two predominant compounds with...

Cite
Jakusch T, Dean A, Oncsik T, et al. Vanadate complexes in serum: a speciation modeling study. Dalton Trans. 2009;(1):212-20doi: 10.1039/b914849c.
Jakusch, T., Dean, A., Oncsik, T., Bényei, A. C., Di Marco, V., & Kiss, T. (2010). Vanadate complexes in serum: a speciation modeling study. Dalton transactions (Cambridge, England : 2003), (1), 212-20. https://doi.org/10.1039/b914849c
Jakusch, Tamás, et al. "Vanadate complexes in serum: a speciation modeling study." Dalton transactions (Cambridge, England : 2003) vol. ,1 (2010): 212-20. doi: https://doi.org/10.1039/b914849c
Jakusch T, Dean A, Oncsik T, Bényei AC, Di Marco V, Kiss T. Vanadate complexes in serum: a speciation modeling study. Dalton Trans. 2010 Jan 07;(1):212-20. doi: 10.1039/b914849c. Epub 2009 Nov 05. PMID: 20023952.
Copy Download .nbib Format: NLM
Comparison of the Antiproliferative Activity of Two Antitumour Ruthenium(III) Complexes With Their Apotransferrin and Transferrin-Bound Forms in a Human Colon Cancer Cell Line.

Metal-based drugs

Kratz F, Keppler BK, Hartmann M, Messori L, Berger MR.
PMID: 18472789
Met Based Drugs. 1996;3(1):15-23. doi: 10.1155/MBD.1996.15.

Two ruthenium(III) complexes, namely trans-indazolium[tetrachlorobis(indazole)- ruthenate(III)], HInd[RuInd(2)Cl(4)] and trans-imidazolium[tetrachlorobis(imidazole)- ruthenate(III)], HIm[RuIm(2)Cl(4)] exhibit high anticancer activity in an autochthonous colorectal carcinoma model in rats. Recently, it has been shown that both complexes bind specifically to human serum apotransferrin and the...

Cite
Kratz F, Keppler BK, Hartmann M, et al. Comparison of the Antiproliferative Activity of Two Antitumour Ruthenium(III) Complexes With Their Apotransferrin and Transferrin-Bound Forms in a Human Colon Cancer Cell Line. Met Based Drugs. 1996;3(1):15-23doi: 10.1155/MBD.1996.15.
Kratz, F., Keppler, B. K., Hartmann, M., Messori, L., & Berger, M. R. (1996). Comparison of the Antiproliferative Activity of Two Antitumour Ruthenium(III) Complexes With Their Apotransferrin and Transferrin-Bound Forms in a Human Colon Cancer Cell Line. Metal-based drugs, 3(1), 15-23. https://doi.org/10.1155/MBD.1996.15
Kratz, F, et al. "Comparison of the Antiproliferative Activity of Two Antitumour Ruthenium(III) Complexes With Their Apotransferrin and Transferrin-Bound Forms in a Human Colon Cancer Cell Line." Metal-based drugs vol. 3,1 (1996): 15-23. doi: https://doi.org/10.1155/MBD.1996.15
Kratz F, Keppler BK, Hartmann M, Messori L, Berger MR. Comparison of the Antiproliferative Activity of Two Antitumour Ruthenium(III) Complexes With Their Apotransferrin and Transferrin-Bound Forms in a Human Colon Cancer Cell Line. Met Based Drugs. 1996;3(1):15-23. doi: 10.1155/MBD.1996.15. PMID: 18472789; PMCID: PMC2365000.
Copy Download .nbib Format: NLM
β-Thalassemia: evolving treatment options beyond transfusion and iron chelation.

Hematology. American Society of Hematology. Education Program

Langer AL, Esrick EB.
PMID: 34889443
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):600-606. doi: 10.1182/hematology.2021000313.

After years of reliance on transfusion alone to address anemia and suppress ineffective erythropoiesis in β-thalassemia, many new therapies are now in development. Luspatercept, a transforming growth factor-β inhibitor, has demonstrated efficacy in reducing ineffective erythropoiesis, improving anemia, and...

Cite
Langer AL, Esrick EB. β-Thalassemia: evolving treatment options beyond transfusion and iron chelation. Hematology Am Soc Hematol Educ Program. 2021;2021(1):600-606doi: 10.1182/hematology.2021000313.
Langer, A. L., & Esrick, E. B. (2021). β-Thalassemia: evolving treatment options beyond transfusion and iron chelation. Hematology. American Society of Hematology. Education Program, 2021(1), 600-606. https://doi.org/10.1182/hematology.2021000313
Langer, Arielle L, and Esrick, Erica B. "β-Thalassemia: evolving treatment options beyond transfusion and iron chelation." Hematology. American Society of Hematology. Education Program vol. 2021,1 (2021): 600-606. doi: https://doi.org/10.1182/hematology.2021000313
Langer AL, Esrick EB. β-Thalassemia: evolving treatment options beyond transfusion and iron chelation. Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):600-606. doi: 10.1182/hematology.2021000313. PMID: 34889443.
Copy Download .nbib Format: NLM
Role of protein supplements in the culture of mouse embryos.

Theriogenology

Natsuyama S, Noda Y, Narimoto K, Mori T.
PMID: 16727301
Theriogenology. 1993 Jul;40(1):149-57. doi: 10.1016/0093-691x(93)90348-9.

The effect of various types of proteins used in single protein supplements for Bigger-Whitten-Whittingham (BWW) medium on the in vitro development of mouse preimplantation embryos was evaluated. Thioredoxin, superoxide dismutase (SOD), and apotransferrin showed prominent growth-promoting activity, whereas bovine...

Cite
Natsuyama S, Noda Y, Narimoto K, et al. Role of protein supplements in the culture of mouse embryos. Theriogenology. 1993;40(1):149-57doi: 10.1016/0093-691x(93)90348-9.
Natsuyama, S., Noda, Y., Narimoto, K., & Mori, T. (1993). Role of protein supplements in the culture of mouse embryos. Theriogenology, 40(1), 149-57. https://doi.org/10.1016/0093-691x(93)90348-9
Natsuyama, S, et al. "Role of protein supplements in the culture of mouse embryos." Theriogenology vol. 40,1 (1993): 149-57. doi: https://doi.org/10.1016/0093-691x(93)90348-9
Natsuyama S, Noda Y, Narimoto K, Mori T. Role of protein supplements in the culture of mouse embryos. Theriogenology. 1993 Jul;40(1):149-57. doi: 10.1016/0093-691x(93)90348-9. PMID: 16727301.
Copy Download .nbib Format: NLM
A target-specific oral formulation of Doxorubicin-protein nanoparticles: efficacy and safety in hepatocellular cancer.

Journal of Cancer

Golla K, Bhaskar C, Ahmed F, Kondapi AK.
PMID: 24155776
J Cancer. 2013 Sep 14;4(8):644-52. doi: 10.7150/jca.7093. eCollection 2013.

BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) also known as malignant hepatoma is a most common liver cancer. Doxorubicin (Doxo) is an anti-cancer drug having activity against a wide spectrum of cancer types. Clinical Utility of doxo has been limited due to...

Cite
Golla K, Bhaskar C, Ahmed F, et al. A target-specific oral formulation of Doxorubicin-protein nanoparticles: efficacy and safety in hepatocellular cancer. J Cancer. 2013;4(8):644-52doi: 10.7150/jca.7093.
Golla, K., Bhaskar, C., Ahmed, F., & Kondapi, A. K. (2013). A target-specific oral formulation of Doxorubicin-protein nanoparticles: efficacy and safety in hepatocellular cancer. Journal of Cancer, 4(8), 644-52. https://doi.org/10.7150/jca.7093
Golla, Kishore, et al. "A target-specific oral formulation of Doxorubicin-protein nanoparticles: efficacy and safety in hepatocellular cancer." Journal of Cancer vol. 4,8 (2013): 644-52. doi: https://doi.org/10.7150/jca.7093
Golla K, Bhaskar C, Ahmed F, Kondapi AK. A target-specific oral formulation of Doxorubicin-protein nanoparticles: efficacy and safety in hepatocellular cancer. J Cancer. 2013 Sep 14;4(8):644-52. doi: 10.7150/jca.7093. eCollection 2013. PMID: 24155776; PMCID: PMC3805992.
Copy Download .nbib Format: NLM
Protein-binding Properties of two Antitumour Ru(III) Complexes to Human Apotransferrin and Apolactoferrin.

Metal-based drugs

Kratz F, Keppler BK, Messori L, Smith C, Baker EN.
PMID: 18476228
Met Based Drugs. 1994;1(2):169-73. doi: 10.1155/MBD.1994.169.

The interaction of two ruthenium(III) complexes exhibiting high anticancer activity - namely trans-Indazolium(bisindazole) tetrachlororuthenate(III), Hlnd[RuInd(2)Cl(4)], and trans-Imidazolium (bisimidazole) tetrachlororuthenate(III), Hlm[RuIm(2)Cl(4)], - with human serum apotransferrin has been investigated through spectroscopic and chromatographic techniques with the ultimate goal of preparing...

Cite
Kratz F, Keppler BK, Messori L, et al. Protein-binding Properties of two Antitumour Ru(III) Complexes to Human Apotransferrin and Apolactoferrin. Met Based Drugs. 1994;1(2):169-73doi: 10.1155/MBD.1994.169.
Kratz, F., Keppler, B. K., Messori, L., Smith, C., & Baker, E. N. (1994). Protein-binding Properties of two Antitumour Ru(III) Complexes to Human Apotransferrin and Apolactoferrin. Metal-based drugs, 1(2), 169-73. https://doi.org/10.1155/MBD.1994.169
Kratz, F, et al. "Protein-binding Properties of two Antitumour Ru(III) Complexes to Human Apotransferrin and Apolactoferrin." Metal-based drugs vol. 1,2 (1994): 169-73. doi: https://doi.org/10.1155/MBD.1994.169
Kratz F, Keppler BK, Messori L, Smith C, Baker EN. Protein-binding Properties of two Antitumour Ru(III) Complexes to Human Apotransferrin and Apolactoferrin. Met Based Drugs. 1994;1(2):169-73. doi: 10.1155/MBD.1994.169. PMID: 18476228; PMCID: PMC2364888.
Copy Download .nbib Format: NLM
Maghemite nanoparticles stabilize the protein corona formed with transferrin presenting different iron-saturation levels.

Nanoscale

Martens U, Böttcher D, Talbot D, Bornscheuer U, Abou-Hassan A, Delcea M.
PMID: 31432845
Nanoscale. 2019 Aug 29;11(34):16063-16070. doi: 10.1039/c9nr04967c.

Magnetic nanoparticles are ideal candidates for biomedical applications given their potential use in magnetic resonance imaging, magnetic hyperthermia and targeted drug delivery. Understanding protein-nanoparticle interactions in the blood stream is of major importance due to their potential risks, especially...

Cite
Martens U, Böttcher D, Talbot D, et al. Maghemite nanoparticles stabilize the protein corona formed with transferrin presenting different iron-saturation levels. Nanoscale. 2019;11(34):16063-16070doi: 10.1039/c9nr04967c.
Martens, U., Böttcher, D., Talbot, D., Bornscheuer, U., Abou-Hassan, A., & Delcea, M. (2019). Maghemite nanoparticles stabilize the protein corona formed with transferrin presenting different iron-saturation levels. Nanoscale, 11(34), 16063-16070. https://doi.org/10.1039/c9nr04967c
Martens, Ulrike, et al. "Maghemite nanoparticles stabilize the protein corona formed with transferrin presenting different iron-saturation levels." Nanoscale vol. 11,34 (2019): 16063-16070. doi: https://doi.org/10.1039/c9nr04967c
Martens U, Böttcher D, Talbot D, Bornscheuer U, Abou-Hassan A, Delcea M. Maghemite nanoparticles stabilize the protein corona formed with transferrin presenting different iron-saturation levels. Nanoscale. 2019 Aug 29;11(34):16063-16070. doi: 10.1039/c9nr04967c. PMID: 31432845.
Copy Download .nbib Format: NLM
Topoisomerase II β Gene Specific siRNA Delivery by Nanoparticles Prepared with c-ter Apotransferrin and its Effect on HIV-1 Replication.

Molecular biotechnology

Sunnam LBK, Kondapi AK.
PMID: 33993458
Mol Biotechnol. 2021 Aug;63(8):732-745. doi: 10.1007/s12033-021-00334-7. Epub 2021 May 16.

Topoisomerase II beta (Topo IIβ) is one of the two isoforms of type II topoisomerases present in higher eukaryotes. This 180 kDa nuclear protein involves in different cellular processes like transcription, recombination, etc., apart from its normal topological functions....

Cite
Sunnam LBK, Kondapi AK. Topoisomerase II β Gene Specific siRNA Delivery by Nanoparticles Prepared with c-ter Apotransferrin and its Effect on HIV-1 Replication. Mol Biotechnol. 2021;63(8):732-745doi: 10.1007/s12033-021-00334-7.
Sunnam, L. B. K., & Kondapi, A. K. (2021). Topoisomerase II β Gene Specific siRNA Delivery by Nanoparticles Prepared with c-ter Apotransferrin and its Effect on HIV-1 Replication. Molecular biotechnology, 63(8), 732-745. https://doi.org/10.1007/s12033-021-00334-7
Sunnam, Lokeswara Bala Krishna, and Kondapi, Anand K. "Topoisomerase II β Gene Specific siRNA Delivery by Nanoparticles Prepared with c-ter Apotransferrin and its Effect on HIV-1 Replication." Molecular biotechnology vol. 63,8 (2021): 732-745. doi: https://doi.org/10.1007/s12033-021-00334-7
Sunnam LBK, Kondapi AK. Topoisomerase II β Gene Specific siRNA Delivery by Nanoparticles Prepared with c-ter Apotransferrin and its Effect on HIV-1 Replication. Mol Biotechnol. 2021 Aug;63(8):732-745. doi: 10.1007/s12033-021-00334-7. Epub 2021 May 16. PMID: 33993458.
Copy Download .nbib Format: NLM
The Interaction of the Antitumor Complexes Na[trans-RuCl(4) (DMSO)(Im)] and Na[trans-RuCl(4)(DMSO)(Ind)] With Apotransferrin: a Spectroscopic Study.

Metal-based drugs

Messori L, Kratz F, Alessio E.
PMID: 18472787
Met Based Drugs. 1996;3(1):1-9. doi: 10.1155/MBD.1996.1.

The interaction of two antitumor ruthenium(III) complexes,-Na[trans-RuCl(4)(DMSO)(Im)] and Na[trans-RuCl(4)(DMSO)(Ind)]- with human serum apotransferrin (apoTf) was investigated through a number of spectroscopic techniques such as UV-Vis absorption, CD and (1)H NMR spectroscopy. Interestingly, the hydrolysis profiles of these complexes in...

Cite
Messori L, Kratz F, Alessio E. The Interaction of the Antitumor Complexes Na[trans-RuCl(4) (DMSO)(Im)] and Na[trans-RuCl(4)(DMSO)(Ind)] With Apotransferrin: a Spectroscopic Study. Met Based Drugs. 1996;3(1):1-9doi: 10.1155/MBD.1996.1.
Messori, L., Kratz, F., & Alessio, E. (1996). The Interaction of the Antitumor Complexes Na[trans-RuCl(4) (DMSO)(Im)] and Na[trans-RuCl(4)(DMSO)(Ind)] With Apotransferrin: a Spectroscopic Study. Metal-based drugs, 3(1), 1-9. https://doi.org/10.1155/MBD.1996.1
Messori, L, et al. "The Interaction of the Antitumor Complexes Na[trans-RuCl(4) (DMSO)(Im)] and Na[trans-RuCl(4)(DMSO)(Ind)] With Apotransferrin: a Spectroscopic Study." Metal-based drugs vol. 3,1 (1996): 1-9. doi: https://doi.org/10.1155/MBD.1996.1
Messori L, Kratz F, Alessio E. The Interaction of the Antitumor Complexes Na[trans-RuCl(4) (DMSO)(Im)] and Na[trans-RuCl(4)(DMSO)(Ind)] With Apotransferrin: a Spectroscopic Study. Met Based Drugs. 1996;3(1):1-9. doi: 10.1155/MBD.1996.1. PMID: 18472787; PMCID: PMC2365001.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries